Christopher Bartalos
Gastroenterology · Lees Summit, MONPI 1720076607
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 94 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 26.0% of the total. Reporting peaked in 2019 at $582 and has fallen 72.6% since, to $159 in 2022. That places this record below the midpoint for gastroenterology clinicians in MO, where the typical reported total is $1,415.
Across 94 payments — averaging $13.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$329
- Pfizer$305
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$218
- Takeda Pharmaceuticals U.S.A., Inc.$197
- Apollo Endosurgery US Inc$73
- Daiichi Sankyo Inc.$27
- plus $114 from 7 others
Across 214 payments — averaging $3815.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$232K
- AbbVie$190K
- Janssen Research & Development, LLC$105K
- Eli Lilly$67K
- Boehringer Ingelheim International GmbH$56K
- Takeda Pharmaceuticals U.S.A., Inc.$50K
- plus $116K from 9 others
What the payments were for
- Food & beverage$1,264100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $329 |
| Pfizer | 28 | $305 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $197 |
| Apollo Endosurgery US Inc | 2 | $73 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Ironwood Pharmaceuticals, Inc | 2 | $25 |
| Intercept Pharmaceuticals, Inc. | 2 | $24 |
| Shionogi Inc | 1 | $17 |
| Merck | 1 | $14 |
| Bristol Myers Squibb | 1 | $12 |
| Braintree Laboratories, Inc. | 1 | $11 |
| UCB, Inc. | 1 | $11 |
How this compares
$1,264 in reported general payments places this provider in the 45th percentile of 374 gastroenterology providers in Missouri.
Other gastroenterology in Lees Summit
- Marc TaorminaLees Summit$55K
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$730K
- David AlpersSaint Louis$616K
- Kamran QureshiLake St Louis$279K
- Laith Al MomaniKansas City$249K
- Ahmed SaeedKansas City$246K
- Parakkal DeepakSaint Louis$205K
- Bradley AndersonColumbia$194K
- Mauricio Lisker MelmanSaint Louis$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.